VBIV Annual Total Long Term Liabilities
$3.69 M
-$50.29 M-93.17%
31 December 2023
Summary:
As of February 5, 2025, VBIV annual total long term liabilities is $3.69 million, with the most recent change of -$50.29 million (-93.17%) on December 31, 2023. During the last 3 years, it has fallen by -$16.63 million (-81.85%).VBIV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly Long Term Liabilities
$3.32 M
-$372.00 K-10.09%
31 March 2024
Summary:
As of February 5, 2025, VBIV quarterly total long term liabilities is $3.32 million, with the most recent change of -$372.00 thousand (-10.09%) on March 31, 2024. Over the past year, it has dropped by -$48.59 million (-93.61%).VBIV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.2% | -93.6% |
| 3 y3 years | -81.8% | -93.9% |
| 5 y5 years | -77.1% | -93.9% |
VBIV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -93.2% | -93.9% |
VBI Vaccines Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $3.32 M(-10.1%) |
| Dec 2023 | $3.69 M(-93.2%) | $3.69 M(-0.4%) |
| Sept 2023 | - | $3.70 M(-92.9%) |
| June 2023 | - | $51.91 M(-3.6%) |
| Mar 2023 | - | $53.87 M(-0.2%) |
| Dec 2022 | $53.98 M(+59.7%) | $53.98 M(+0.9%) |
| Sept 2022 | - | $53.51 M(+105.3%) |
| June 2022 | - | $26.07 M(-14.4%) |
| Mar 2022 | - | $30.45 M(-9.9%) |
| Dec 2021 | $33.81 M(+66.4%) | $33.81 M(+8.6%) |
| Sept 2021 | - | $31.14 M(+2.1%) |
| June 2021 | - | $30.48 M(+59.9%) |
| Mar 2021 | - | $19.06 M(-6.2%) |
| Dec 2020 | $20.32 M(+385.1%) | $20.32 M(+2.6%) |
| Sept 2020 | - | $19.80 M(+2.1%) |
| June 2020 | - | $19.39 M(+428.4%) |
| Mar 2020 | - | $3.67 M(-12.4%) |
| Dec 2019 | $4.19 M(-74.0%) | $4.19 M(-4.0%) |
| Sept 2019 | - | $4.36 M(+14.3%) |
| June 2019 | - | $3.82 M(-76.9%) |
| Mar 2019 | - | $16.55 M(+2.9%) |
| Dec 2018 | $16.09 M(+27.4%) | $16.09 M(+24.5%) |
| Sept 2018 | - | $12.93 M(-4.7%) |
| June 2018 | - | $13.56 M(+9.9%) |
| Mar 2018 | - | $12.35 M(-2.3%) |
| Dec 2017 | $12.63 M(-5.8%) | $12.63 M(-2.2%) |
| Sept 2017 | - | $12.92 M(-2.2%) |
| June 2017 | - | $13.22 M(-1.0%) |
| Mar 2017 | - | $13.35 M(-0.5%) |
| Dec 2016 | $13.41 M(+597.7%) | $13.41 M(+1208.2%) |
| Sept 2016 | - | $1.02 M(-55.8%) |
| June 2016 | - | $2.32 M(+15.3%) |
| Mar 2016 | - | $2.01 M(+4.7%) |
| Dec 2015 | $1.92 M | $1.92 M(+12.4%) |
| Sept 2015 | - | $1.71 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Mar 2015 | $0.00(0.0%) | - |
| Dec 2014 | - | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | $0.00(-100.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | $48.64 M(>+9900.0%) | $48.64 M(>+9900.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | - | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | - | $0.00(0.0%) |
| Mar 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2004 | - | $173.30 K(+8.2%) |
| Sept 2004 | - | $160.10 K(+38.3%) |
| June 2004 | - | $115.80 K(-5.9%) |
| Mar 2004 | $123.00 K(+308.6%) | $123.00 K(+4292.9%) |
| Dec 2003 | - | $2800.00(-98.1%) |
| Sept 2002 | - | $148.20 K(+392.4%) |
| Mar 2000 | $30.10 K | $30.10 K |
FAQ
- What is VBI Vaccines annual total long term liabilities?
- What is the all time high annual total long term liabilities for VBI Vaccines?
- What is VBI Vaccines annual total long term liabilities year-on-year change?
- What is VBI Vaccines quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for VBI Vaccines?
- What is VBI Vaccines quarterly long term liabilities year-on-year change?
What is VBI Vaccines annual total long term liabilities?
The current annual total long term liabilities of VBIV is $3.69 M
What is the all time high annual total long term liabilities for VBI Vaccines?
VBI Vaccines all-time high annual total long term liabilities is $53.98 M
What is VBI Vaccines annual total long term liabilities year-on-year change?
Over the past year, VBIV annual total long term liabilities has changed by -$50.29 M (-93.17%)
What is VBI Vaccines quarterly total long term liabilities?
The current quarterly long term liabilities of VBIV is $3.32 M
What is the all time high quarterly long term liabilities for VBI Vaccines?
VBI Vaccines all-time high quarterly total long term liabilities is $53.98 M
What is VBI Vaccines quarterly long term liabilities year-on-year change?
Over the past year, VBIV quarterly total long term liabilities has changed by -$48.59 M (-93.61%)